Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO EBITDA Margin

EBITDA as a percentage of revenue.

Medical Facilities CorporationTSX: DR.TO

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 22.8%

EBITDA Margin was 22.8% in Q1 FY2026, up 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 24.7%, down 1.0 pp year over year. Over 3 fiscal years it widened by 10.9 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 27.8% for the fiscal year ending Dec 2026, up from 23.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
22.8%-4.5 pp QoQ
Last fiscal yearDec 2025
23.0%-1.9 pp YoY
LTMMar 2026
24.7%-1.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.6 pp-9.6 pp-10.2 pp
1 year-1.9 pp+4.8 pp+6.8 pp
3 years+10.9 pp+1.2 pp-9.7 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
23.0%
Year-over-year change
-1.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How DR.TO compares with its peers on the latest reported figures

  • DR.TO's LTM Mar 2026 EBITDA Margin of 24.7% is the 2nd highest of the 8 companies compared; the peer median is -10.5%.
  • Its year-over-year change of -1.0 pp is the 7th highest of 8, against a peer median of +19.6 pp.
  • Over three fiscal years its change of +10.9 pp compares with a peer median of +139.5 pp.
DR.TO Competitors Peer median
EBITDA Margin for DR.TO and competitors
Company Period LTM level YoY 3-year change
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202631.0% +5.0 pp+133.5 pp
DR.TOMedical Facilities CorporationLTM Mar 202624.7% -1.0 pp+10.9 pp
TSND.TOTerrAscend Corp.LTM Mar 202623.1% +19.6 pp+126.3 pp
CRRX.TOCareRx CorporationLTM Mar 20268.0% +1.5 pp+8.3 pp
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-10.5% +23.0 pp+1464.5 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-14.9% -18.5 pp—
WEED.TOCanopy Growth CorporationLTM Mar 2026-20.4% +157.8 pp+798.1 pp
PRN.TOProfound Medical Corp.LTM Mar 2026-194.3% +121.3 pp+145.4 pp
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
Peer median (excluding DR.TO) -10.5%+19.6 pp+139.5 pp

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.